市場調查報告書
商品編碼
1451657
2024-2032 年伴侶動物保健市場報告(按動物類型、產品、最終用戶和地區)Companion Animal Health Market Report by Animal Type, Product, End User, and Region 2024-2032 |
2023年,全球伴侶動物保健市場規模達到254億美元。展望未來, IMARC Group預計到2032年該市場將達到505億美元,2024-2032年複合年成長率(CAGR)為7.7%。全球寵物擁有率的不斷上升、獸醫保健的不斷進步以及對人畜共患疾病的認知不斷提高,導致對動物保健產品和服務的需求增加,是推動市場的一些主要因素。
市場成長與規模:在寵物擁有上升和人們對寵物健康意識提高的推動下,市場目前正在經歷顯著成長。該市場涵蓋廣泛的產品和服務,包括藥品、疫苗、診斷劑和飼料添加劑,以滿足寵物的健康需求。
主要市場促進因素:主要促進因素包括寵物擁有率的提高、獸醫保健的進步以及對人畜共患疾病的日益關注。這些因素導致對各種動物保健產品和服務的需求增加。
技術進步:技術創新,特別是在診斷和治療選擇方面,正在推動市場成長。遠距醫療和健康應用程式等數位技術的整合正在提高獸醫護理的可及性和效率。
產業應用:該市場在伴侶動物的預防保健、疾病治療、營養管理和慢性病監測方面得到應用。獸醫醫院和診所以及家庭檢測是其他關鍵應用領域。
主要市場趨勢:主要趨勢包括對預防性醫療保健的日益重視、寵物保險的興起以及對個人化寵物護理解決方案的日益偏好。市場也正在轉向更天然和有機的寵物保健產品。
地理趨勢:北美地區引領市場,而亞太地區則因生活方式的改變和經濟發展而呈現快速成長。歐洲也憑藉其高標準的寵物照護和監管框架保持著強大的市場地位。
競爭格局:市場的特徵是存在多家從事研發(R&D)、策略聯盟和擴展產品組合的領導企業。競爭基於產品創新、品質和品牌聲譽。
挑戰與機會:挑戰包括監管障礙、獸醫護理成本高昂以及不同地區獲得先進醫療保健的機會差異。然而,新興市場、具成本效益產品的開發以及遠距醫療服務需求的不斷成長蘊藏著許多機會。
未來展望:伴侶動物保健產業預計將繼續其成長軌跡,重點關注先進的醫療保健解決方案、個人化醫療和永續實踐。這個市場可能會受益於持續的技術創新和對動物福利的日益重視。
提高寵物擁有率
由於全球寵物擁有率不斷上升,伴侶動物保健市場目前正在顯著成長。這在很大程度上歸因於社會規範的變化,寵物越來越被視為家庭的一部分。這種與寵物的情感連結導致人們更加關注它們的健康和福祉,從而推動了對各種動物保健產品和服務的需求。城市化、消費者可支配收入增加以及動物健康意識不斷增強等因素進一步推動了這一趨勢。隨著寵物主人的資訊越來越豐富,他們正在為寵物尋求更好的醫療保健、營養和保健產品,這反過來又推動了伴侶動物保健市場的成長。
獸醫保健的進步
獸醫保健領域的不斷進步也推動了市場的發展。這些進步涵蓋了廣泛的領域,包括診斷、治療和預防保健。此外,新疫苗、藥物和診斷工具的開發使得能夠更有效和高效地治療各種動物疾病。遠距醫療和行動醫療應用等獸醫實踐中的技術整合也發揮著至關重要的作用。這些技術創新提高了為伴侶動物提供的護理質量,並提高了寵物主人獲得獸醫服務的可及性和便利性。這一因素對於促進伴侶動物健康市場的成長至關重要,因為它直接影響為寵物提供及時有效的醫療保健解決方案的能力。
人們越來越關注人畜共通傳染病
人們對人畜共通傳染病(可以從動物傳播給人類的疾病)的認知和關注不斷增強,這是刺激伴侶動物健康市場的另一個重要因素。最近的冠狀病毒(COVID-19)大流行尤其提高了人們對人畜共患病潛在風險的認知。因此,人們越來越重視監測和預防伴侶動物的此類疾病。這一趨勢正在促進針對人畜共患病原體的疫苗和治療方法的研發(R&D)的大量投資。除此之外,世界各地的監管機構和動物衛生組織現在更加重視制定嚴格的指導方針和預防措施,這反過來又刺激了對動物保健產品和服務的需求。對預防人畜共通傳染病的日益關注對於公共衛生至關重要,也有助於支持伴侶動物健康市場的成長。
The global companion animal health market size reached US$ 25.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032. The rising pet ownership rates worldwide, continuous advancements in veterinary healthcare, and heightened awareness of zoonotic diseases, leading to increased demand for animal health products and services, are some of the major factors propelling the market.
Market Growth and Size: The market is currently experiencing significant growth, driven by the rising trend of pet ownership and heightened awareness about pet health. This market encompasses a wide range of products and services, including pharmaceuticals, vaccines, diagnostics, and feed additives, catering to the health needs of pets.
Major Market Drivers: Key drivers include the increasing rates of pet ownership, advancements in veterinary healthcare, and a growing focus on zoonotic diseases. These factors are leading to a higher demand for various animal health products and services.
Technological Advancements: Technological innovations, particularly in diagnostics and treatment options, are propelling the market growth. The integration of digital technologies, such as telemedicine and health apps, is enhancing the accessibility and efficiency of veterinary care.
Industry Applications: The market finds its applications in preventive care, treatment of diseases, nutritional management, and chronic condition monitoring in companion animals. Veterinary hospitals and clinics, along with in-home testing, are other key application areas.
Key Market Trends: Major trends include the increasing emphasis on preventive healthcare, the rise of pet insurance, and the growing preference for personalized pet care solutions. The market is also seeing a shift toward more natural and organic pet health products.
Geographical Trends: North America leads the market, while the Asia Pacific region shows rapid growth due to changing lifestyles and economic development. Europe also maintains a strong market presence with its high standards of pet care and regulatory framework.
Competitive Landscape: The market is characterized by the presence of several leading players engaging in research and development (R&D), strategic alliances, and expansion of product portfolios. Competition is based on product innovation, quality, and brand reputation.
Challenges and Opportunities: Challenges include regulatory hurdles, high costs of veterinary care, and disparities in access to advanced healthcare in different regions. However, numerous opportunities lie in emerging markets, the development of cost-effective products, and the escalating demand for telehealth services.
Future Outlook: The companion animal health industry is expected to continue its growth trajectory, with a heightened focus on advanced healthcare solutions, personalized medicine, and sustainable practices. This market is likely to benefit from ongoing technological innovations and a growing emphasis on animal welfare.
Increasing Pet Ownership Rates
The companion animal health market is currently witnessing significant growth due to the rising rates of pet ownership globally. This can be largely attributed to changing societal norms where pets are increasingly considered as part of the family. This emotional bonding with pets is leading to a greater focus on their health and well-being, thereby driving demand for various animal health products and services. Factors such as urbanization, inflating consumer disposable incomes, and the growing awareness of animal health are further contributing to this trend. As pet owners are becoming more informed, they are seeking better healthcare, nutrition, and wellness products for their pets, which, in turn, is fueling the growth of the companion animal health market.
Advancements in Veterinary Healthcare
The market is also being propelled by the ongoing advancements in veterinary healthcare. These advancements encompass a wide range of areas, including diagnostics, therapeutics, and preventive care. Moreover, the development of new vaccines, pharmaceuticals, and diagnostic tools is enabling more effective and efficient treatment of various animal diseases. The integration of technology in veterinary practices, such as telemedicine and mobile health applications, is also playing a crucial role. These technological innovations improve the quality of care provided to companion animals and enhance the accessibility and convenience of veterinary services for pet owners. This factor is crucial in augmenting the growth of the companion animal health market as it directly impacts the ability to provide timely and effective healthcare solutions for pets.
Growing Focus on Zoonotic Diseases
The growing awareness and concern regarding zoonotic diseases - illnesses that can be transmitted from animals to humans - is another significant factor stimulating the companion animal health market. The recent coronavirus (COVID-19) pandemic has particularly led to a heightened awareness about the potential risks posed by zoonotic diseases. As a result, there is an increased emphasis on monitoring and preventing such diseases in companion animals. This trend is fostering substantial investments in research and development (R&D) of vaccines and treatments that target zoonotic pathogens. Besides this, regulatory bodies and animal health organizations worldwide are now more focused on establishing stringent guidelines and preventive measures, which in turn are catalyzing the demand for animal health products and services. This rising focus on preventing zoonotic diseases is crucial for public health as well as instrumental in supporting the growth of the companion animal health market.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on animal type, product, and end user.
Dogs
Cats
Equine
Others
Dogs account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the animal type. This includes dogs, cats, equine, and others. According to the report, dogs represented the largest segment.
The dogs segment holds the largest share in the companion animal health market, reflecting the widespread ownership of dogs as pets globally. This segment benefits from the strong emotional bond between dogs and their owners, leading to considerable spending on healthcare, nutrition, and wellness products. Dog owners are increasingly seeking preventive healthcare, regular check-ups, and advanced treatments for their pets, driving demand for a range of products from pharmaceuticals to specialized diets. Innovations in dog healthcare, including advanced therapeutics and diagnostics, are also key factors contributing to the growth of this segment. The market for dogs is further strengthened by the rising trend of pet humanization, where owners treat their dogs as family members, ensuring high-quality healthcare and lifestyle products.
The cats segment in the companion animal health market is significant, fueled by the growing popularity of cats as pets, especially in urban settings. Cat owners are becoming more attentive to their pets' health needs, leading to increased demand for cat-specific healthcare products and services. This segment is experiencing growth in areas such as routine health check-ups, vaccinations, and chronic disease management. Additionally, there is a rising interest in specialized nutrition and wellness products tailored for cats, including age-specific and breed-specific formulations. The market is also witnessing a widespread adoption of advanced diagnostic and treatment options for cats, reflecting the growing concern for their well-being among pet owners.
The equine segment, though smaller compared to dogs and cats, plays a vital role in the market. This segment caters to the health and wellness needs of horses, with a focus on both preventive care and treatment of illnesses. The market is driven by the needs of professional breeders, equestrian sports enthusiasts, and individual horse owners. There is a significant demand for vaccinations, parasite control products, and nutritional supplements specific to horses. Additionally, the segment is seeing advancements in diagnostic and treatment technologies, including imaging and surgical procedures tailored for equine health. The rising interest in equestrian sports and recreational horse riding also contributes to the steady growth of this segment.
Vaccines
Pharmaceuticals
Feed Additives
Diagnostics
Others
A detailed breakup and analysis of the market based on the product have also been provided in the report. This includes vaccines, pharmaceuticals, feed additives, diagnostics, and others.
Vaccines play a vital role in preventing various infectious diseases in pets. This segment is driven by increasing awareness about the importance of regular vaccinations for pets, along with the development of new and more effective vaccines. Innovations in vaccine technology, such as recombinant vaccines and DNA vaccines, are enhancing the efficacy and safety profiles of these products. The demand for vaccines is also being strengthened by stringent regulations and recommendations by veterinary bodies, emphasizing the necessity of vaccinations as a part of preventive healthcare for companion animals.
The pharmaceuticals segment is a major component of the companion animal health market, encompassing a wide range of products, including anti-infectives, anti-inflammatories, and medicines for chronic conditions. This segment is expanding owing to the increasing prevalence of numerous health issues in pets, such as arthritis, diabetes, and heart disease. The development of new and more effective drugs, along with the growing trend of personalized medicine, is further driving this segment. Moreover, the rise in pet insurance and veterinary care spending is enabling pet owners to afford these pharmaceutical treatments, thereby contributing to the growth of this segment.
Feed additives play a significant role in the companion animal health market, focusing on improving the nutrition and overall health of pets. This segment includes a range of products like vitamins, minerals, amino acids, and probiotics, which are essential for the proper growth, development, and health maintenance of companion animals. The escalating demand for premium and specialized pet foods, coupled with the heightened understanding of the importance of nutrition in animal health, is fostering the growth of this segment. Additionally, the development of new and innovative feed additives that cater to specific health needs, such as digestive health or immune support, is further enhancing the market potential.
The diagnostics segment in the companion animal health market is gaining momentum, propelled by the increasing adoption of advanced diagnostic methods for accurate and early detection of diseases in pets. This segment includes a variety of diagnostic tools and services, such as blood tests, imaging, and molecular diagnostics. The growth in this segment is catalyzed by technological advancements, which are making diagnostics more accessible and cost-effective. Pet owners' growing preference for preventive healthcare measures, coupled with the need for regular health monitoring of aging pets, is also accelerating the expansion of this market segment. The integration of digital technologies, such as telemedicine, is further facilitating the growth and reach of diagnostic services in the companion animal health sphere.
Point-of-Care Testing/In-House Testing
Veterinary Hospitals and Clinics
Others
Veterinary hospitals and clinics represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end user. This includes point-of-care testing/in-house testing, veterinary hospitals and clinics, and others. According to the report, veterinary hospitals and clinics represented the largest segment.
Veterinary hospitals and clinics serve as the primary care providers for companion animals. This segment includes a comprehensive range of services, from routine check-ups and vaccinations to advanced surgical procedures and emergency care. The dominance of this segment is attributed to the comprehensive care these facilities provide, backed by skilled veterinary professionals and advanced medical technologies. Veterinary hospitals and clinics are essential for diagnosing and treating more complex health conditions in pets, which cannot be addressed through in-house testing alone. The rising focus on preventive healthcare, along with the increasing prevalence of various animal diseases and conditions, continues to drive pet owners to seek professional veterinary services, thereby sustaining the growth and significance of this market segment.
The point-of-care testing (POCT) or in-house testing segment in the companion animal health market caters to the growing demand for convenient and rapid diagnostic testing. This segment includes a range of diagnostic tools and kits used by pet owners or veterinarians at home or in non-laboratory settings. The growth in this segment is supported by the increasing preference for immediate results and the convenience of conducting tests without the need for specialized equipment or external laboratory services. Technological advancements have led to the development of more accurate and user-friendly testing kits, making in-house testing a viable option for routine health monitoring and disease screening in pets. This segment is particularly appealing to pet owners who seek proactive management of their pets' health, offering an efficient way to monitor chronic conditions or perform regular health check-ups.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest companion animal health market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to high pet ownership rates, substantial spending on pet care, and the presence of advanced veterinary healthcare infrastructure. This region is characterized by a strong emphasis on preventive care and wellness for pets, fueling the demand for a wide range of products and services, from vaccines to diagnostic tools. Additionally, the presence of major market players and continuous investment in research and development (R&D) in this region contribute to its leading position. The emerging trend of pet humanization, where pets are treated as family members, further propels the growth of the market in North America.
The Asia Pacific region is also experiencing rapid growth in the companion animal health market, driven by increasing pet ownership, rising disposable incomes, and heightened awareness of pet health and wellness. Urbanization and changing lifestyles are leading to a greater adoption of pets, particularly in emerging economies. The region is witnessing an increase in demand for quality veterinary services and healthcare products. Additionally, the expansion of veterinary healthcare facilities and the entry of international players into these markets are contributing to the growth of the market in the Asia Pacific region.
Europe holds a significant share of the companion animal health market, supported by high standards of pet care, well-established veterinary healthcare systems, and stringent animal health regulations. The market in this region is propelled by a strong focus on preventive care, advanced diagnostics, and treatment options. European pet owners are typically well-informed and willing to invest in the health and well-being of their pets, further supporting market growth. Moreover, Europe's strong regulatory framework ensures the availability of high-quality and safe animal health products, contributing to the growth of the market in this region.
The companion animal health market in Latin America is growing steadily, with an increasing number of households owning pets and a heightened awareness of pet health needs. The market is expanding owing to the gradual improvement in veterinary healthcare infrastructure and services. Economic growth in various countries in this region is enabling pet owners to spend more on pet care, including preventive and therapeutic products. However, the market still faces challenges, such as limited access to advanced veterinary care in some areas, which influences the overall growth potential of this segment.
The Middle East & Africa region, though smaller compared to other segments, is gradually emerging in the companion animal health market. This growth is attributed to increasing pet ownership in urban areas and rising awareness of pet health and welfare. The market is also benefiting from the growing investment in veterinary services and infrastructure. However, the region faces unique challenges, such as varying levels of economic development and cultural attitudes toward pet ownership, which impact the market dynamics. Nonetheless, the increasing focus on animal health and welfare in these regions offers potential for growth in the companion animal health sector.
Numerous key players in the companion animal health market are actively engaging in research and development (R&D) to innovate new products and services, focusing on areas like advanced therapeutics, diagnostics, and preventive care. They are also expanding their global reach through strategic partnerships, mergers, and acquisitions, aiming to enhance their product portfolios and market presence. Additionally, these companies are investing in digital technologies, such as telemedicine and mobile applications, to improve accessibility and efficiency in veterinary care. Emphasizing customer education and awareness programs, they aim to increase the understanding of pet health needs, thereby driving market growth and customer loyalty.
Agrolabo S.p.A.
Boehringer Ingelheim
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
IDEXX Laboratories Inc.
Indian Immunologicals Limited (National Dairy Development Board)
Merck & Co. Inc.
Norbrook Laboratories
Vetoquinol SA
Virbac
Zoetis Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
In September 2023, Ceva Sante Animale (Ceva), the global animal health company, announced the launch of its highly anticipated 2024 "Call for Projects". This worldwide event aims to discover and support new, innovative solutions for the well-being and care of companion animals and their pet parents.
In October 2023, Zoetis announced the U.S. commercial launch of Librela (bedinvetmab injection), demonstrating the company's advanced leadership in canine innovation and dedication to providing individualized care to address the health needs of dogs. Librela was approved by the U.S. Food and Drug Administration (FDA) on May 5, 2023, as a once-monthly injectable monoclonal antibody for the control of pain associated with osteoarthritis (OA) in dogs, helping to improve the mobility and quality of life for dogs with OA pain.